98-4125. Notice Pursuant to the National Cooperative Research and Production Act of 1993International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA-134A (IPACT-I)

[Federal Register Volume 63, Number 33 (Thursday, February 19, 1998)]
[Notices]
[Page 8477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-4125]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--International Pharmaceutical Aerosol Consortium 
for Toxicology Testing of HFA-134A (IPACT-I)

    Notice is hereby given that, on December 3, 1997, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), The International 
Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA-134a 
(``IPACT-I'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing a change 
in membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, the following has become a new member to the IPACT-I: 
Aeropharm Technology, Inc., Edison, NJ, a subsidiary of Kos 
Pharmaceuticals, Inc.
    No other changes have been made in either the membership or planned 
activity of IPACT-I. Membership in this group research project remains 
open, and IPACT-I intends to file additional written notification 
disclosing all changes in membership.
    On August 7, 1990, IPACT-I filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
September 6, 1990 (55 FR 36710).
    The last notification was filed with the Department on March 6, 
1997. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on April 3, 1997 (62 FR 15939).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 98-4125 Filed 2-18-98; 8:45 am]
BILLING CODE 4410-11-M